Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

8.4K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.4K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.5K
2.5K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.9K
2.9K
Allosteric Regulation01:08

Allosteric Regulation

62.1K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
62.1K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.3K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

15.6K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biased Signaling as Allosteric Probe Dependence: Everything Old Is New Again.

Biochemistry·2026
Same author

Therapeutic implications of target residence time.

Current opinion in structural biology·2026
Same author

Structure-based design of an opioid receptor modulator for enhanced morphine analgesia.

Science advances·2026
Same author

Differential Effects of Sodium on Agonist-Induced Conformational Transitions and Signaling at μ and κ Opioid Receptors.

Biochemistry·2025
Same author

Agonism and Biased Signaling.

Handbook of experimental pharmacology·2025
Same author

Differential effects of sodium on agonist-induced conformational transitions and signaling at μ and κ opioid receptors.

bioRxiv : the preprint server for biology·2025
Same journal

Targeting lipoprotein lipase-positive macrophage-driven GDF-15 expression alleviates cancer Cachexia in obese head and neck squamous cell carcinoma.

Cellular signalling·2026
Same journal

BRD8 promotes non-small cell lung cancer progression by stabilizing MBD2 and activating the MAPK pathway.

Cellular signalling·2026
Same journal

Hypoxia remodels circSTX6 nuclear export through URH49-ALYREF to drive IGF1-mediated bladder cancer progression.

Cellular signalling·2026
Same journal

Integrative spatiotemporal analysis uncovers an Fto-mediated epigenetic-metabolic axis governing myocardial ischemic injury.

Cellular signalling·2026
Same journal

Caspase-3 activation is a brake in GSDMD-mediated pyroptosis.

Cellular signalling·2026
Same journal

ILF3 promotes proliferation and invasion of hepatocellular carcinoma cells through STAT3 phosphorylation and formation of an endogenous complex with SRPK1.

Cellular signalling·2026
See all related articles

Related Experiment Video

Updated: Nov 28, 2025

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

29.9K

Biased signaling as allosteric probe dependence.

Terry Kenakin1

  • 1Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Cellular Signalling
|November 26, 2020
PubMed
Summary
This summary is machine-generated.

Seven transmembrane receptor bias allows specific signaling pathway activation for therapeutic benefit. Quantifying this receptor bias for in vivo applications remains a significant challenge requiring further research.

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

13.2K
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

16.8K

Related Experiment Videos

Last Updated: Nov 28, 2025

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

29.9K
Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

13.2K
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

16.8K

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • Seven transmembrane receptors (STRs) exhibit allosteric probe dependence, leading to biased signaling.
  • This phenomenon allows different agonists to stabilize receptor conformations that preferentially activate certain signaling pathways over others.

Purpose of the Study:

  • To explore the therapeutic potential of exploiting biased signaling in STRs.
  • To review current strategies and limitations in harnessing receptor bias for drug development.

Main Methods:

  • Discussion of recent research and theoretical concepts related to biased signaling.
  • Analysis of the challenges in quantifying receptor bias for in vivo translation.

Main Results:

  • Biased signaling offers potential therapeutic advantages by selectively modulating cellular responses.
  • Current methods for determining quantitative measures of receptor bias are insufficient for practical in vivo application.

Conclusions:

  • Harnessing biased signaling in STRs presents a promising avenue for novel therapeutics.
  • Further research is crucial to develop reliable methods for quantifying receptor bias and its in vivo effects.